Literature DB >> 21116273

Immune complex formation in IgA nephropathy: CD89 a 'saint' or a 'sinner'?

Joanna K Boyd1, Jonathan Barratt.   

Abstract

New data suggest that a soluble form of the IgA receptor CD89 may be protective against development of progressive renal injury in IgA nephropathy (IgAN). Understanding how IgA triggers shedding of CD89 from myeloid cell surfaces could help clarify the process of immune complex formation in IgAN, and measurement of this soluble form of CD89 may in the future prove a useful prognostic indicator of end-stage renal disease in this common glomerulonephritis.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21116273     DOI： 10.1038/ki.2010.365

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  13 in total

Review 1.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

Review 2.  The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy.

Authors:  Luis Sanchez-Russo; Arun Rajasekaran; Sofia Bin; Jeremiah Faith; Paolo Cravedi
Journal:  Kidney360       Date:  2022-06-27

3.  Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.

Authors:  Xinfang Xie; Pan Liu; Li Gao; Xue Zhang; Ping Lan; Vanesa Bijol; Jicheng Lv; Hong Zhang; Jing Jin
Journal:  J Pathol       Date:  2021-04-09       Impact factor: 7.996

4.  Poly-IgA Complexes and Disease Severity in IgA Nephropathy.

Authors:  Xue Zhang; Jicheng Lv; Pan Liu; Xinfang Xie; Manliu Wang; Dan Liu; Hong Zhang; Jing Jin
Journal:  Clin J Am Soc Nephrol       Date:  2021-10-04       Impact factor: 8.237

5.  Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.

Authors:  Laureline Berthelot; Christina Papista; Thiago T Maciel; Martine Biarnes-Pelicot; Emilie Tissandie; Pamela H M Wang; Houda Tamouza; Agnès Jamin; Julie Bex-Coudrat; Aurelie Gestin; Ahmed Boumediene; Michelle Arcos-Fajardo; Patrick England; Evangéline Pillebout; Francine Walker; Eric Daugas; François Vrtosvnik; Martin Flamant; Marc Benhamou; Michel Cogné; Ivan C Moura; Renato C Monteiro
Journal:  J Exp Med       Date:  2012-03-26       Impact factor: 14.307

6.  Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN).

Authors:  Maria De Angelis; Eustacchio Montemurno; Maria Piccolo; Lucia Vannini; Gabriella Lauriero; Valentina Maranzano; Giorgia Gozzi; Diana Serrazanetti; Giuseppe Dalfino; Marco Gobbetti; Loreto Gesualdo
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

Review 7.  Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.

Authors:  Colin Reily; Hiroyuki Ueda; Zhi-Qiang Huang; Jiri Mestecky; Bruce A Julian; Christopher D Willey; Jan Novak
Journal:  J Immunol Res       Date:  2014-07-23       Impact factor: 4.818

8.  Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.

Authors:  Lijun Xu; Bingyu Li; Mengwen Huang; Kun Xie; Dong Li; You Li; Hua Gu; Jianmin Fang
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

Review 9.  New insights into the pathogenesis of IgA nephropathy.

Authors:  See Cheng Yeo; Chee Kay Cheung; Jonathan Barratt
Journal:  Pediatr Nephrol       Date:  2017-06-17       Impact factor: 3.714

Review 10.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Authors:  Barbora Knoppova; Colin Reily; Nicolas Maillard; Dana V Rizk; Zina Moldoveanu; Jiri Mestecky; Milan Raska; Matthew B Renfrow; Bruce A Julian; Jan Novak
Journal:  Front Immunol       Date:  2016-04-12       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.